|
|
|
|
| LEADER |
01582nam a2200349 u 4500 |
| 001 |
EB001892095 |
| 003 |
EBX01000000000000001055242 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200301 r ||| eng |
| 100 |
1 |
|
|a Ho, Chuong
|
| 245 |
0 |
0 |
|a Nabilone for the treatment of nausea and vomiting or anorexia
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Chuong Ho, Danielle MacDougall
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c February 27, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (18 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Nausea / drug therapy
|
| 653 |
|
|
|a Anorexia / drug therapy
|
| 653 |
|
|
|a Antiemetics / therapeutic use
|
| 653 |
|
|
|a Vomiting / drug therapy
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Dronabinol / therapeutic use
|
| 653 |
|
|
|a Guidelines as Topic
|
| 700 |
1 |
|
|a MacDougall, Danielle
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546996
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This report aims to review the clinical effectiveness of nabilone for the treatment of nausea, vomiting, or anorexia. Guidelines associated with the use of nabilone for the treatment of nausea, vomiting, or anorexia will also be examined
|